Principal investigator: An Junqi
StrokeFacial paralysisHeadache & vertigoEpilepsyParkinson's diseaseInsomnia, anxiety & depressionDementia
The TCM Neurology specialty includes a cerebrovascular disease ward and a muscular atrophy ward.
Neurology Department
- A key research laboratory of the State Administration of TCM for collateral disease and a key TCM specialty of Hebei Province.
- Under the leadership of Academician Wu Yiling, it follows a path of "high standards for acute and critical illness, distinctive treatment for chronic disease", with a one-stop stroke system covering emergency care and rehabilitation.
- 14 doctors (4 chief physicians, 2 associate chief physicians, 5 attending physicians, 3 resident physicians; 1 PhD and 7 master's degree holders) and 21 nurses.
- Milestones: named a Hebei Provincial Key TCM Specialty in 2018; second inpatient ward established in 2019; certified as a Stroke Prevention and Treatment Center in 2021.
- Techniques include whole-brain angiography, arteriovenous thrombolysis and interventional thrombectomy for acute cerebral infarction, intravascular stent placement and cerebral aneurysm embolization.
Conditions treated: stroke (prodromal, recovery and sequelae phases), facial paralysis, headache, dizziness/vertigo, epilepsy and Parkinson's disease, as well as insomnia, anxiety, depression and dementia.
Approach: guided by collateral theory and based on herbal decoctions combined with acupuncture, physiotherapy, massage, fumigation, modern rehabilitation and functional training. Treatment is individualized through syndrome differentiation to restore movement and sensation, improve self-care and quality of life, prevent relapse and ease the burden on family caregivers.
Muscular Atrophy Specialty
- A key TCM specialty of the State Administration of TCM and a demonstration base for ALS care. For over 30 years it has treated muscular atrophy disorders with TCM, including motor neuron disease, muscular dystrophy, myasthenia gravis, multiple sclerosis and syringomyelia.
- Its treatment system is built on extraordinary-vessel theory. In more than 20 years it has treated about 100,000 patient visits from China and abroad (including Russia, Japan, Pakistan, Egypt, Poland, the United States, Canada and Australia), with reported improvements in symptoms, pain, muscle strength, quality of life and survival.
- Motor neuron disease: "treatment from extraordinary vessels, combined with five-organ syndrome differentiation and Triple Burner treatment", leading to the Jiwei Ling preparation and related formulas.
- Progressive muscular dystrophy: a collateral and extraordinary-vessel framework with a "multi-element, stepwise" comprehensive treatment.
- Myasthenia gravis: the first approach to use extraordinary-vessel and collateral theory together, treating deficiency of extraordinary yang, depletion of primordial qi and stagnation of collateral qi by warming extraordinary yang, supporting primordial qi and unblocking collateral qi.
- Syringomyelia and multiple sclerosis: based on "kidney–governor vessel and collateral" theory, replenishing essence and marrow and invigorating the governor vessel and collaterals.
About the principal investigator: An Junqi
Research and publications: took part in four provincial/municipal research projects and a National Natural Science Foundation project; one China Association of Chinese Medicine Science and Technology Award and three provincial/municipal science and technology progress awards. Editor-in-chief of five professional books, deputy editor of two, contributor to three, and author of over 30 papers.
Expertise: nearly 40 years in neurology, focusing on acute and chronic cerebrovascular disease, vertigo, epilepsy and Alzheimer's/senile dementia, using a "four-in-one" approach that combines thrombolysis, surgery, intervention and TCM syndrome-based treatment with limb rehabilitation, specialty herbs and acupuncture/physiotherapy to reduce disability and speed recovery.
An Junqi
Chief TCM Practitioner
Deputy Director of Hebei Medical University Yiling Hospital and Director of the Neurology Department; adjunct professor at Hebei Medical University and Hebei University of Chinese Medicine.
- Outstanding young and middle-aged expert of Shijiazhuang
- Vice President, Hebei Cerebrovascular Disease Prevention Association
- Member of the China Association of Chinese Medicine, the Hebei Cardiovascular and Cerebrovascular Professional Committee, the Hebei Chinese Medicine Association and its Bi-Zheng Professional Committee, and the Hebei Association of Integrated Chinese and Western Medicine
- Director, Hebei Vascular Health and Technology Association
Planning a clinical trial with us?
Contact the Drug Clinical Trial Institution Office, 4th floor, Outpatient Building, 385 Xinshi North Road, Shijiazhuang. Reception hours: weekdays 8:30–11:30 and 14:00–17:00.